1128 infection control & hospital epidemiology october 2015, vol. 36, no. 10
result in transmission among patients who had viral genetic analysis performed.
acknowledgments
Financial support. The VA. Potential conflicts of interest. All authors report no conflicts of interest rele-
vant to this article. Address correspondence to Patricia Schirmer, MD, Office of Public Health
Surveillance and Research, 3801 Miranda Ave (132), Palo Alto, CA 94304 (
Patricia.Schirmer@
va.gov).
supplementary material
To view supplementary material for this article, please visit
http://dx.doi.org/10.1017/ice.2015.165
references
1. Healthcare inspection-inappropriate use of insulin pens VA Wes- tern New York Healthcare System Buffalo, New York. Report No. 13-01320-200. Department of Veteran Affairs Office of Inspector General website.
http://www.va.gov/oig/pubs/VAOIG-13-01320- 200.pdf. Published 2013. AccessedMay 22, 2014.
2. Insulin pens and pen needles. BDDiabetes Learning Center website.
http://www.bd.com/us/diabetes/page.aspx?cat=7001&id=7254. AccessedMay 22, 2014.
3. Le Floch JP, Herbreteau C, Lange F, Perlemuter L. Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients. Diabetes Care 1998;21:1502–1504.
4. Herdman M, Larck C, Schliesser S, Jelic T. Biological con- tamination of insulin pens in a hospital setting. Am J Health Syst Pharm 2013;70:1244–1248.
5. Sonoki K, Yoshinari M, Iwase M, et al. Regurgitation of blood into insulin cartridges in the pen-like injectors. Diabetes Care 2001;24:603–604.
6. Cross contamination with insulin pens. ISMP Medication Safety Alert website.
http://www.ismp.org/newsletters/acutecare/articles/ 20080327_1.asp. Published 2008. AccessedMay 22, 2014.
7. Considering Insulin pens for routine hospital use? ISMP Medi- cation Safety Alert website.
http://www.ismp.org/newsletters/ acutecare/articles/
20080508.asp. Published 2008. Accessed May 22, 2014.
8. Reuse of insulin pen for multiple patients risks transmission of bloodborne disease. ISMP Medication Safety Alert website.
http://www.ismp.org/newsletters/acutecare/articles/20090212-2. asp. Published 2009. Accessed May 22, 2014.
9. Information for healthcare professionals: risk of transmission of blood-borne pathogens from shared use of insulin pens. US Food and Drug Administration website.
http://www.fda.gov/Drugs/Drug- Safety/PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/
ucm133352.htm. Published 2009. AccessedMay 22, 2014.
10. Insulin pens must never be used for more than one person. Centers for Disease Control and Prevention Clinical Reminder website.
http://www.cdc.gov/injectionsafety/clinical-reminders/ insulin-pens.html. Published 2012. Accessed May 22, 2014.
11. AL No. 13-04-Multi-dose pen injectors. VA Patient Safety Alert website.
http://www.patientsafety.va.gov/docs/alerts/AL13-04 MultiDosePens.pdf. Published 2013. Accessed May 22, 2014.
13. VHA Directive 1058. Office of Research and Oversight website.
http://www1.va.gov/vhapublications/ViewPublication.asp? pub_ID=1825. Published 2009. Accessed September 25, 2014.
14. Sullivan KM, Dean A, Soe MM. OpenEpi: a web-based epide- miologic and statistical calculator for public health. Public Health Rep 2009;124:471–474.
15. Bukh J, MillerRH, PurcellRH. Genetic heterogeneity of hepatitisC virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41–63.
16. Kato N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb Comp Genomics 2000;5:129–151.
17. Cody S, Nainan O, Garfein R, et al. Hepatitis C virus transmission from an anesthesiologist to a patient. Arch Intern Med 2002; 162:345–350.
18. Nainan O, Alter M, Kruszon Moran D, et al. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology 2006;131:478–484.
19. Patel P, Larson AK, Castel A, et al. Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies. JAMA 2006;296:2005–2011.
20. Ramachandran S, Xia G-L, Ganova Raeva L, Nainan O, Khu- dyakov Y. End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: perfor- mance under optimal and suboptimal conditions. J Virol Methods 2008;151:217–224.
21. Thompson ND, Hellinger WC, Kay RS, et al. Healthcare- associated hepatitis C virus transmission among patients in an abdominal organ transplant center. Transpl Infect Dis 2009; 11:324–329.
22. Hakre S, Upshaw Combs D, Sanders Buell E, et al. An investiga- tion of bloodborne pathogen transmission due to multipatient sharing of insulin pens. Mil Med 2012;177:930–938.
23. Nassau University Medical Center press release. Nassau University Medical Center website.
http://www.nuhealth.net/pressrelease detail.asp?ID=340. Published 2008. Accessed May 22, 2014.
24. Dean Clinic says patients may have been exposed to hepatitis, HIV. Wisconsin State Journal website.
http://host.madison.com/ news/local/health_med_fit/dean-clinic-says-patients-may-have- been-exposed-to-hepatitis/article_5806e8b6-d261-11e0-8dcb-
001cc4c002e0.html. Published 2011. Accessed July 6, 2015.
25. Olean General Hospital press release. Olean General Hospital website.
http://www.ogh.org/programs-and-services/diabetes/Press% 20Release-OGH%20Alerts%20Patients%20to%20Possible%20Insulin %20Pen%20Re-use.pdf. Published 2013. AccessedMay 22, 2014.
26. Kuehn B. FDA warns against shared insulin pens. JAMA 2009;301:1527.
27. Ochs R. Nassau Medical Center extends warning over insulin pen. Newsday website.
http://www.diabeticconnect.com/diabetes-news/ general/324-nassau-medical-center-extends-warning-over-insulin- pen. Published 2008. Accessed May 22, 2014.
12. Healthcare inspection—review of veterans health administration follow-up on inappropriate use of insulin pens at medical facilities. Report No 13-01987-263. Department of Veteran Affairs Office of Inspector General website.
http://www.va.gov/oig/pubs/VAOIG- 13-01987-263.pdf. Published 2013. Accessed March 24, 2015.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140